English Name | GMP | DMF | Spec. | Current status |
Meloxicam | Y | Y | USP / EP | Commercial |
Nimodipine | Y | Y | EP | Commercial |
Glimepiride | Y | N | EP/JP | Commercial |
Carbidopa | CEP to be entitled FDA under evaluation | Y | EP/USP | Commercial |
Calcium Polycarbophil | Y | Y | USP | Commercial |
Sevelamer Carbonate | Y | N | In-house | Commercial |
Sevelamer Hydrochloride | Y | N | In-house | Commercial |
Sodium Rabeprazole | Y | N | In-house | Commercial |
NOTES: All other different packaging sizes can be provided according to customer’s requirements.
Tel: 86-533-2196808,2196814. Contact Person: Mr.Wu Licheng wulicheng@xhzy.com； Philip Yang yanghongfei@xhzy.com
